TriSalus Life Sciences (TLSI) Capital Expenditures (2022 - 2026)
TriSalus Life Sciences (TLSI) reported Capital Expenditures of $141000.0 for Q1 2026, down 81.3% on a YoY basis from $754000.0 in Q1 2025, and up 2720.0% quarter-over-quarter from $5000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Capital Expenditures (2022 - 2026) Analysis & Trends
TriSalus Life Sciences has reported Capital Expenditures for 5 years, with the latest figure at $141000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 81.3% year-over-year to $141000.0; the trailing twelve-month figure through Mar 2026 stood at -$545000.0 (down 149.59% YoY), and the FY2025 full-year result was $68000.0, down 80.29% from the prior year.
- Capital Expenditures for Q1 2026 stood at $141000.0, up from $5000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $754000.0 in Q1 2025, with the low at -$734000.0 in Q2 2025.
- Historically, Capital Expenditures has averaged $122363.6 across 5 years, with a median of $141000.0 in 2026.
- Annual changes were most pronounced in 2023 — Capital Expenditures surged 82.35% — and 2025, when it tumbled 98.55%.
- TriSalus Life Sciences' Capital Expenditures stood at $204000.0 in 2022, then surged by 82.35% to $372000.0 in 2023, then retreated by 7.26% to $345000.0 in 2024, then plunged by 98.55% to $5000.0 in 2025, then soared by 2720.0% to $141000.0 in 2026.
- The last three Capital Expenditures figures came in at $141000.0 (Q1 2026), $5000.0 (Q4 2025), and $43000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | TriSalus Life Sciences | 209.25 Mn | 152.70 Mn | 7.67 Mn | 141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | -734,000.00 |
| Jun 30, 2025 | -734,000.00 |
| Mar 31, 2025 | 754,000.00 |
| Mar 31, 2025 | 754,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |